Psoriasis: Is it the tip of the iceberg for the quality of life of patients and their families?

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 11, 2011, Pages 1282-1287

  Tadros, A ^a   Vergou, T ^a   Stratigos, A J ^a   Tzavara, C ^b   Hletsos, M ^c   Katsambas, A ^a   Antoniou, C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

DLQI; EQ5D; FDLQI; psoriasis; QoL; SF 36

Indexed keywords

ADALIMUMAB; CALCIPOTRIOL; CORTICOSTEROID; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; ETRETIN; INFLIXIMAB; METHOTREXATE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; DERMATOLOGY LIFE QUALITY INDEX; DRUG WITHDRAWAL; EUROQOL INDEX; FAMILY; FEMALE; GUTTATE PSORIASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PSORIATIC ERYTHRODERMA; PUSTULAR PSORIASIS; PUSTULOSIS PALMOPLANTARIS; PUVA; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FAMILY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 80054013048     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03965.x     Document Type: Article

References (19)

1. Mease PJ, Menter MA,. Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective. J Am Acad Dermatol 2006; 54: 685-704.
2. Mukhtar R, Choi J, Koo JY,. Quality-of-life issues in psoriasis. Dermatol Clin 2004; 22: 389-395. (Pubitemid 39140770)
3. Basra MK, Finlay AY,. The family impact of skin diseases: the Greater Patient concept. Br J Dermatol 2007; 156: 929-937. (Pubitemid 46642834)
4. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216. (Pubitemid 24194579)
5. Ware JE Jr, Sherbourne CD,. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
6. Szende A, Oppe M, Devlin N,. EQ-5D value sets: inventory, comparative review and user guide. EUROQOL Group monographs, Vol 2. Springer Publications, 2007.
7. Basra MK, Sue-Ho R, Finlay AY,. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol 2007; 156: 528-538.
8. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY,. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
9. Katugampola RP, Hongbo Y, Finlay AY,. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life. Br J Dermatol 2005; 152: 1256-1262. (Pubitemid 40933426)
10. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-407. (Pubitemid 29418506)
11. Kimball AB, Guerin A, Mulani P, et al. The risk of coronary heart disease and stroke among psoriasis patients. Abstract P 3369 AAD. J Am Acad Dermatol 2009; 60: Suppl AB179.
12. Ludwig RJ, Herzog C, Rostock A, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007; 156: 271-276. (Pubitemid 46095954)
13. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM,. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-835. (Pubitemid 44556851)
14. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE,. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755-760. (Pubitemid 27496193)
15. Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D,. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol 2002; 147: 736-742. (Pubitemid 35286160)
16. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ,. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002; 47: 512-518.
17. Feldman SR, Fleischer AB Jr, Reboussin DM, et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997; 37: 564-569. (Pubitemid 27446725)
18. Eghlileb AM, Basra MK, Finlay AY,. The psoriasis family index: preliminary results of validation of a quality of life instrument for family members of patients with psoriasis. Dermatology 2009; 219: 63-70.
19. Basra MK, Edmunds O, Salek MS, Finlay AY,. Measurement of family impact of skin disease: further validation of the Family Dermatology Life Quality Index (FDLQI). J Eur Acad Dermatol Venereol 2008; 22: 813-821. (Pubitemid 351837115)